Abstract
Familial mediterranean fever (FMF) is an autoinflammatory disease characterized by recurrent attacks of fever, peritonitis, pleuritis, and genetically by autosomal recessive inheritance. The major renal involvement in FMF is the occurrence of amyloidosis that can be prevented by a daily regimen of colchicine. About 5–10% of cases with familial mediterranean fever may be resistant to colchicine. In literature, there is a controversy about the treatment of FMF patients resistant to colchicine. We describe a case with FMF, proteinuria, and bilateral sacroiliitis, which responded to anti-TNF (tumor necrosis factor)-alpha therapy with infliximab and etanercept.
References
Nakamura A, Matsuda M, Tazawa K, Shimojima Y, Ikeda S (2007) Successful treatment with infliximab and low-dose methotrexate in a Japanese patient with familial mediterranean fever. Intern Med 46(15):1247–1249
El-Shanti HI (2003) Familial mediterranean fever and renal disease. Saudi J Kidney Dis Transpl 14(3):378–385
Ben-Chetrit E, Levy M (1998) Familial mediterranean fever. Lancet 351:659–664
Lidar M, Scherrmann JM, Shinar Y, Chetrit A, Niel E, Gershoni-Baruch R, Langevitz P, Livneh A (2004) Colchicine nonresponsiveness in familial mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization. Arthritis Rheum 33(4):273–282
Brik R, Shinawi M, Kasinetz L, Gershoni-Baruch R (2001) The musculoskeletal manifestations of familial mediterranean fever in children genetically diagnosed with the disease. Arthritis Rheum 44(6):1416–1419
Incel NA, Saracoglu M, Erdem HR (2003) Seronegative spondiloarthropathy of familial mediterranean fever. Rheum Int 23(1):41–43
Ozen S, Bakkaloglu A, Yilmaz E, Duzova A, Balci B, Topaloglu R, Besbas N (2003) Mutations in the gene for familial mediterranean fever: do they predispose to inflammation. J Rheum 30(9):2014–2018
Metyas S, Arkfeld DG, Forrester DM, Ehresmann GR (2004) Infliximab treatment of familial mediterranean fever and its effect on secondary AA amyloidosis. J Clin Rheum 10(3):134–137
Sakallioglu O, Duzova A, Ozen S (2006) Etanercept in the treatment of arthritis in a patient with familial mediterranean fever. Clin Exp Rheumatol 24:435–437
Ozgocmen S, Ozçakar L, Ardicoglu O, Kocakoc E, Kaya A, Kiris A (2006) Familial Mediterranean sfever responds well to infliximab: single case experience. Clin Rheumatol 25:83–87
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Erten, S., Erten, S.F. & Altunoglu, A. Successful treatment with anti-tumor necrosis factor (anti-TNF)-alpha of proteinuria in a patient with familial mediterranean fever (FMF) resistant to colchicine: anti-TNF drugs and FMF. Rheumatol Int 32, 1095–1097 (2012). https://doi.org/10.1007/s00296-011-1855-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-011-1855-5